Instrument Inactif

Autres langues Ludwig Enterprises, Inc. Other OTC

Actions

LUDG

US54973P4019

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	20/05
Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024	19/03
Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	19/03
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers	06/03
Ludwig Enterprises Inc. Announces Patent Filing for Breakthrough in Identifying Mrna Genes Associated with Certain Cancers	06/03
Ludwig Enterprises, Inc. announced that it has received $0.04 million in funding	12/02
Ludus Enterprises, Inc. Receives Continuing Review Approval on Planned Clinical Study from Advarra IRB, Columbia, MD	31/01
Ludwig Enterprises, Inc. Announces Executive Changes	01/12
Ludwig Enterprises, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
Ludwig Enterprises, Inc. Appoints Scott Silverman as Chief Financial Officer	16/11
Ludwig Enterprises, Inc. Announces Marvin S. Hausman as Chief Executive Officer	19/09/23
Ludwig Enterprises, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23
Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	21/06/23
Ludwig Enterprises Announces Launches of New Nutraceutical and Strategic Marketing Plan	25/04/23
Ludwig Enterprises Launches Nugenea, Groundbreaking Nutraceutical to Fight Inflammation	12/04/23
Ludwig Enterprises, Inc. Auditor Raises 'Going Concern' Doubt	15/02/23
Ludwig Enterprises, Inc. Receives Institutional Review Board Approval on Bladder Cancer Study	03/01/23
Precision Genomics (a Ludwig Company) Will Break Major Medical News at a Presentation for LD Micro Tuesday, Oct. 25th, 2022	24/10/22
Ludwig Enterprises Files A Patent That Could Be A Major Technology Breakthrough in Healthcare	22/09/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Ludwig Enterprises, Inc. Other OTC

Actions

LUDG

US54973P4019

Autres langues

Filtres